Search Results - "Gumà, J."

The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5 by Guaita-Esteruelas, S, Gumà, J, Masana, L, Borràs, J

“…The adipose tissue microenvironment plays a key role in tumour initiation and progression because it provides fatty acids and adipokines to tumour cells. The…”
Get full text

Clinical Pattern and Therapeutic Results Achieved in 1490 Patients with Germ-Cell Tumours of the Testis: the Experience of the Spanish Germ-Cell Cancer Group (GG) by Germà-Lluch, J.R, Garcia del Muro, X, Maroto, P, Paz-Ares, L, Arranz, J.A, Gumà, J, Alba, E, Sastre, J, Aparicio, J, Fernández, A, Barnadas, A, Terrassa, J, Sáenz, A, Almenar, D, López-Brea, M, Climent, M.A, Sánchez, M.A, Lasso de la Vega, R, Berenguer, G, Pérez, X

“…Objective: To describe the clinical characteristics and treatment results obtained with the application of a homogeneous treatment protocol in 1490 patients…”
Get full text

A European prospective observational study of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC): PREMISE by Payne, H., Robinson, A., Rappe, B., Hilman, S., De Giorgi, U., Joniau, S., Bordonaro, R., Mallick, S., Dourthe, L., Mira Flores, M., Gumà, J., Baron, B., Duran, A., Pranzo, A., Serikoff, A., De Santis, M.

Get full text

Pain outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving enzalutamide (ENZA) in a real-world setting: PREMISE by Mott, D., Herdman, M., Robinson, A., Rappe, B., Hilman, S., De Giorgi, U., Joniau, S., Bordonaro, R., Mallick, S., Dourthe, L-M., Mira Flores, M., Gumà, J., Payne, H., De Santis, M., Baron, B., Duran, A., Pranzo, A., Serikoff, A., Pavesi, M.

Get full text

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG) by Aparicio, J., Maroto, P., García del Muro, X., Sánchez-Muñoz, A., Gumà, J., Margelí, M., Sáenz, A., Sagastibelza, N., Castellano, D., Arranz, J.A., Hervás, D., Bastús, R., Fernández-Aramburo, A., Sastre, J., Terrasa, J., López-Brea, M., Dorca, J., Almenar, D., Carles, J., Hernández, A., Germà, J.R.

“…We aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the…”
Get full text

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma by Aparicio, J., García del Muro, X., Maroto, P., Paz-Ares, L., Alba, E., Sáenz, A., Terrasa, J., Barnadas, A., Almenar, D., Arranz, J. A., Sánchez, M., Fernández, A., Sastre, J., Carles, J., Dorca, J., Gumà, J., Yuste, A. L., Germà, J. R.

“…Background: After decades of irradiation as standard therapy for clinical stage I testicular seminoma, alternative treatment approaches have emerged including…”
Get full text

GCIMS: An R package for untargeted gas chromatography – Ion mobility spectrometry data processing by Oller-Moreno, S., Mallafré-Muro, C., Fernandez, L., Caballero, E., Blanco, A., Gumà, J., Marco, S., Pardo, A.

“…Gas-Chromatography coupled to Ion Mobility Spectrometry (GC-IMS) based metabolomics is an emerging technique for obtaining fast, reliable untargeted metabolic…”
Get full text

LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL by Cruz‐Merino, L., Martín García‐Sancho, A., Nogales Fernández, E., Carnicero González, F., Ríos Herranz, E., Cruz Vicente, F., Rodríguez García, G., Nicolás García, C., Martínez Benaclocha, N., Gumà Padrò, J., Gómez Codina, J., Salar Silvestre, A., Rodríguez Abreu, D., Quero Blanco, C., Labrador Gómez, J., Guirado Risueño, M., Provencio Pulla, M., Rueda Domínguez, A.

Get full text

Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group by Aparicio, J, Sánchez-Muñoz, A, Ochenduszko, S, Gumà, J, Fernández-Aramburo, A, García Del Muro, X, Quiroga, V, Sastre, J, Alonso-Gordoa, T, Sagastibelza, N, Maroto, P, Gómez de Liaño, A, Vázquez, S, Diz, P, Durán, I, Domenech, M, Pinto, A, Hernández, A, González-Billalabeitia, E, Terrasa, J

“…Stage IS testicular cancer is defined by the persistence of elevated serum tumor markers, including α-fetoprotein and/or β-human chorionic gonadotropin, after…”
Get full text

Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis by Rubió-Casadevall, J., Galceran, J., Ameijide, A., Puigdemont, M., Llauradó, L., Marruecos, J., Izquierdo, A., Carulla, M., Borràs, J. L., Marcos-Gragera, R., Gumà, J.

“…Purpose The diagnosis of a second primary cancer (SPC) is a major concern in the follow-up of survivors of a primary head and neck cancer (HNC), but the…”
Get full text

Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients by Rodríguez-Balada, M., Roig, B., Melé, M., Salvat, M., Martorell, L., Borràs, J., Gumà, J.

“…Purpose Germline promoter hypermethylation of BRCA1 and BRCA2 genes is an alternative event of gene silencing that has not been widely investigated in…”
Get full text

Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group by Aparicio, J., García del Muro, X., Maroto, P., Terrasa, J., Castellano, D., Bastús, R., Gumà, J., Sagastibeltza, N., Durán, I., Ochenduszko, S., Meana, J. A., García-Sánchez, J., Arranz, J. A., Gironés, R., Germà, J. R.

“…Purpose Active surveillance (AS) and adjuvant chemotherapy (AC) with carboplatin are valid alternatives for managing stage I seminoma, and most relapses can be…”
Get full text

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles by Anguera, I, Del Río, A, Miró, J M, Matínez-Lacasa, X, Marco, F, Gumá, J R, Quaglio, G, Claramonte, X, Moreno, A, Mestres, C A, Mauri, E, Azqueta, M, Benito, N, García-de la María, C, Almela, M, Jiménez-Expósito, M-J, Sued, O, De Lazzari, E, Gatell, J M

“…Objective: To evaluate the incidence and the clinical and echocardiographic features of infective endocarditis (IE) caused by Staphylococcus lugdunensis and to…”
Get full text

SEOM clinical guidelines for the management of germ cell testicular cancer (2016) by Aparicio, J., Terrasa, J., Durán, I., Germà-Lluch, J. R., Gironés, R., González-Billalabeitia, E., Gumà, J., Maroto, P., Pinto, A., García-del-Muro, X.

“…Testicular cancer represents the most common malignancy in males aged 15–34 years and is considered a model of curable neoplasm. Maintaining success, reducing…”
Get full text

Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer by Maroto, P, García del Muro, X, Valverde, C, Pinto, A, Sanchez, A, Guma, J, Alonso, T, Martínez del Prado, P, Vazquez, S, Mellado, B, Aparicio, J, Fernandez-Aramburo, A, Girones, R, Terrasa, J

“…•Germ cell cancer is the most frequent solid tumor in young men aged 20 to 40.•Risk factors of a germ cell cancer are age, undescended testis, familial…”
Get full text

HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia by Saballs, M., Parra, S., Sahun, P., Pellejà, J., Feliu, M., Vasco, C., Gumà, J., Borràs, J. L., Masana, L., Castro, A.

“…Objectives To investigate if HDL cholesterol (HDL-c) could be a biomarker of the degree of severity according to prognostic prediction scores in…”
Get full text

Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain by Marcos-Gragera, R., Pollán, M., Chirlaque, M. D., Gumà, J., Sanchez, M. J., Garau, I.

“…Background: Attenuation of the epidemic increase in non-Hodgkin's lymphoma (NHL) incidence has recently been reported in the USA and Nordic European countries…”
Get full text

Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node by Fuertes Manuel, J., Kohan, S., Jordà Solé, M., Mateu Hidalgo, I., Miralles Curto, M., Aguiló Sagristà, O., Aguilar Alomá, E., Peña González, K., Lafuerza Torres, A., Melé Olivé, M., Repkova, J., Montero Jaime, M.J., Gumà Padró, J.

“…To study the feasibility and usefulness of ultrasound-guided pre-chemotherapy marking of pathologic lymph node followed by sentinel lymph node biopsy…”
Get full text

Evaluation of MR imaging-targeted biopsies of the prostate in biopsy-naïve patients. A single centre study by Garcia Bennett, J., Vilanova, J.C., Gumà Padró, J., Parada, D., Conejero, A.

“…To evaluate the differences in prostate cancer detection rate and biopsy effectiveness between magnetic resonance imaging (MRI) target biopsy (TB) and…”
Get full text

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study by Rueda Domínguez, A., Márquez, A., Gumá, J., Llanos, M., Herrero, J., de las Nieves, M. A., Miramón, J., Alba, E.

“…Background: Chemotherapy with ABVD (doxorubicin, bleomycin, vinblastine and darcarbacine) schedule is the standard treatment for advanced Hodgkin's lymphoma…”
Get full text